Abstract
Introduction: Colorectal cancer (CRC) patients are treated with radiotherapy (RT) prior to surgery. However, radiotherapy induces fibrosis and current imaging modalities such as MRI, white-light endoscopy and PET/CT imaging with [18F]FDG or antibody (Ab)-based tracers fail to discriminate between post-RT fibrosis and residual tumor tissue. As a result, complete responders to RT often undergo unnecessary surgery which may have adverse effects. To overcome this problem, this study developed a subcutaneous (s.c.) radiation-induced fibrotic tumor model and evaluated if Nanobody (Nb)-based tracers are able to distinguish between fibrotic and tumor tissue.
Methods: The fibrotic tumor model was developed by subcutaneously inoculating mice with human CRC cells. Once the tumors had a desired size, the tumor was irradiated by a single-irradiation of either 10, 15 or 20 Gy at a dose-rate of 1400 cGy/min. The amount of fibrosis was assessed as the amount of collagen present in the tumors by a Masson’s Trichrome staining either 10, 15 or 25 days post-irradiation.
Subsequently, the fluorescently labeled anti-CEA Nb, was intravenously injected in mice bearing fibrotic tumors according to the optimized conditions from the previous experiment. 1h post-injection of the tracer, tumors were collected and FFPE sections were made. Following an immunofluorescent staining against collagen 1, localization of the tracer to collagen 1 in the tumor was assessed using a fluorescence slide scanner.
Results: Overall, all 3 doses of 10, 15 and 20 Gy resulted in an increase in the amount of fibrotic tissue present in the tumor. However, no real dose-dependent effect was observed. Furthermore, a time-window of 10 and 15 days post-irradiation resulted in more collagen present in the tumor compared to 25 days post-irradiation. Therefore, a time-dependent effect was observed. Compared to the unirradiated tumor, irradiation of the tumor with 15 Gy in combination with a time-window of 15 days post-irradiation were chosen as the optimal parameters to obtain the in vivo fibrotic tumor model.
Next, uptake of the fluorescently labeled anti-CEA Nb in the tumor was observed and a Masson’s Trichrome staining revealed the presence of collagen in the irradiated tumor. Finally, no co-localization of the signal coming from the anti-CEA Nb and collagen 1 was observed.
Conclusion: In this study, Nb-based tracers showed to be able to distinguish between fibrotic and tumor tissue in a s.c. fibrotic tumor model. To further show the added value of Nb-based tracers in this matter, we would like to make a direct comparison between anti-CEA Nb-based and Ab-based tracers. Here we hypothesize that Ab-based tracers will also accumulate in fibrotic and inflammation rich regions in the tumor, limiting their application for this clinical setting. Finally, the anti-CEA Nb can also be conjugated with radioisotopes such as 18F for PET-imaging which may aid in the follow-up of patients post-RT.
Methods: The fibrotic tumor model was developed by subcutaneously inoculating mice with human CRC cells. Once the tumors had a desired size, the tumor was irradiated by a single-irradiation of either 10, 15 or 20 Gy at a dose-rate of 1400 cGy/min. The amount of fibrosis was assessed as the amount of collagen present in the tumors by a Masson’s Trichrome staining either 10, 15 or 25 days post-irradiation.
Subsequently, the fluorescently labeled anti-CEA Nb, was intravenously injected in mice bearing fibrotic tumors according to the optimized conditions from the previous experiment. 1h post-injection of the tracer, tumors were collected and FFPE sections were made. Following an immunofluorescent staining against collagen 1, localization of the tracer to collagen 1 in the tumor was assessed using a fluorescence slide scanner.
Results: Overall, all 3 doses of 10, 15 and 20 Gy resulted in an increase in the amount of fibrotic tissue present in the tumor. However, no real dose-dependent effect was observed. Furthermore, a time-window of 10 and 15 days post-irradiation resulted in more collagen present in the tumor compared to 25 days post-irradiation. Therefore, a time-dependent effect was observed. Compared to the unirradiated tumor, irradiation of the tumor with 15 Gy in combination with a time-window of 15 days post-irradiation were chosen as the optimal parameters to obtain the in vivo fibrotic tumor model.
Next, uptake of the fluorescently labeled anti-CEA Nb in the tumor was observed and a Masson’s Trichrome staining revealed the presence of collagen in the irradiated tumor. Finally, no co-localization of the signal coming from the anti-CEA Nb and collagen 1 was observed.
Conclusion: In this study, Nb-based tracers showed to be able to distinguish between fibrotic and tumor tissue in a s.c. fibrotic tumor model. To further show the added value of Nb-based tracers in this matter, we would like to make a direct comparison between anti-CEA Nb-based and Ab-based tracers. Here we hypothesize that Ab-based tracers will also accumulate in fibrotic and inflammation rich regions in the tumor, limiting their application for this clinical setting. Finally, the anti-CEA Nb can also be conjugated with radioisotopes such as 18F for PET-imaging which may aid in the follow-up of patients post-RT.
| Original language | English |
|---|---|
| Publication status | Unpublished - 17 Jan 2026 |
Fingerprint
Dive into the research topics of 'Comparison of fluorescent Nanobody-based and antibody-based tracers for fluorescence-guided surgery in an in vivo radiation-induced tumor model.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver